New-onset diabetes in elderly subjects: Association between HbA 1c levels, mortality, and coronary revascularization

Diabetes Care

Volumn 36, Issue 11, 2013, Pages 3425-3429

  Twito, Orit ^a,b   Ahron, Ella ^b,c   Jaffe, Anat ^a   Afek, Shani ^b,c   Cohen, Efrat ^c   Granek Catarivas, Martine ^b,c,d   Klein, Pinchas ^a   Hermoni, Doron ^b,c,d  

^a HILLEL YAFFE MEDICAL CENTER   (Israel)

^b MEIR MEDICAL CENTER   (Israel)

^c CLALIT HEALTH SERVICES   (Israel)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEART MUSCLE REVASCULARIZATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; OBSERVATIONAL STUDY; ONSET AGE; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; TRIACYLGLYCEROL BLOOD LEVEL; ANALYSIS; BLOOD; CARDIOVASCULAR DISEASES; COMPLICATION; FEMALE; INCIDENCE; ISRAEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK; VERY ELDERLY;

AGE OF ONSET; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPOGLYCEMIC AGENTS; INCIDENCE; ISRAEL; MALE; RISK;

EID: 84891881654     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-2503     Document Type: Article

References (16)

1. Meneilly GS. Pathophysiology of type 2 diabetes in the elderly. Clin Geriatr Med 1999;15:239-253
2. Motta M, Bennati E, Capri M, Ferlito L, Malaguarnera M. Diabetes mellitus in the extreme longevity. Exp Gerontol 2008;43: 102-105
3. Mozaffarian D, Kamineni A,Carnethon M, Djoussé L, Mukamal KJ, Siscovick D. Lifestyle risk factors and new-onset diabetes mellitus in older adults: the cardiovascular health study. Arch InternMed 2009;169:798-807
4. Crandall J, Schade D, Ma Y, et al.; Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006;61:1075-1081
5. Wang Y, Qin MZ, Liu Q, Liu Q, Chang ZW. Clinical analysis of elderly patients with elderly-onset type 2 diabetes mellitus in China: assessment of appropriate therapy. J Int Med Res 2010;38:1134-1141
6. Smith NL, Barzilay JI, Kronmal R, Lumley T, Enquobahrie D, Psaty BM. New-onset diabetes and risk of all-cause and cardiovascular mortality: the Cardiovascular Health Study. Diabetes Care 2006;29: 2012-2017
7. Bethel MA, Sloan FA, Belsky D, Feinglos MN. Longitudinal incidence and prevalence of adverse outcomes of diabetes mellitus in elderly patients. Arch Intern Med 2007;167:921-927
8. Panzram G, Zabel-Langhennig R. Prognosis of diabetes mellitus in a geographically defined population. Diabetologia 1981;20: 587-591
9. Croxson SC, Price DE, Burden M, Jagger C, Burden AC. The mortality of elderly people with diabetes. Diabet Med 1994; 11:250-252
10. Tan HH, McAlpine RR, James P, et al.; DARTS/MEMO collaboration. Diagnosis of type 2 diabetes at an older age: effect on mortality in men and women. Diabetes Care 2004;27:2797-2799
11. American Diabetes Association. Standards of medical care in diabetesd2012. Diabetes Care 2012;35(Suppl. 1):S11-S63
12. Sinclair A,Morley JE, Rodriguez-Mañas L, et al. Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012;13:497-502
13. Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481-489
14. Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes.N Engl J Med 2008;358:2545-2559
15. Little RR, Rohlfing CL, Tennill AL, et al. Measurement of Hba(1C) in patients with chronic renal failure. Clin Chim Acta 2013;418:73-76
16. Little RR, Tennill AL, Rohlfing C, et al. Can glycohemoglobin be used to assess glycemic control in patientswith chronic renal failure? Clin Chem 2002;48:784-786